CorVel Corp. (CRVL)
NEUTRALFundamental
66
Precio
$69.93
Capitalización Bursátil
$3.61B
Parte 1 · Cuánto vale la empresa
Resumen
CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance y Liquidez
Ingresos
$984M
Últimos 12 meses (hasta 30/6/2026)
Beneficio Neto
$115M
Últimos 12 meses (hasta 30/6/2026)
Flujo de Caja Libre
$110M
Patrimonio Neto Total
$394M
Pasivo Total
$249M
Ratio de Liquidez
1.94
Cobertura de Intereses
-
Deuda/EBITDA
0.15
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$26.35
Precio Actual
$69.93
Margen de Seguridad
-165.4%
Rango de Valor Justo
$21.89 - $30.80
Métodos de Estimación
Métricas de Valoración
Ratio P/E
31.66
ROE
28.0%
Ratio P/B
8.80
P/FCF
31.61
Margen Bruto
24.8%
ROIC
-
Radar de Rentabilidad
Value Creation (Economic Moat)
ROIC
-
WACC
10.3%
ROIC − WACC
-
Criterios de Análisis Fundamental
Superado (14)
- EPS shows upward trend
- Price CAGR 19.12%
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- ROE 29.9%
- Revenue Growth 5Y 11.6%
- Earnings Quality (OCF/NI) 1.31
- Share Dilution -0.8%
- Net Margin Trend 11.7% vs 11.0%
- Piotroski F-Score 7/9
Fallido (7)
- EPS CAGR 0.24%
- Gross Margin 24.8%
- P/FCF 31.61
- P/B Ratio 8.80
- CapEx intensity
- Price below Graham Number
- DCF valuation (Overvalued)
No disponible (7)
- ROIC NaN%
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- Analyst Consensus (Finnhub)
- Earnings Surprise (no valid data)
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Solidez financiera fuerte
Calidad de los Beneficios
Alta calidad: beneficios respaldados por efectivo
Dilución de Acciones
Recomprando acciones. Favorable para el accionista
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Mr. Michael G. Combs | Executive Chair | 61 |
| Mr. Brian S. Nichols | Chief Financial Officer | 44 |
| Ms. Jennifer L. Yoss | Vice President of Accounting | 47 |
| Mr. Maxim Shishin | Chief Information Officer | 50 |
| Mr. Mark E. Bertels | Executive Vice President of Risk Management Services | 62 |
| Ms. Sarah Scott | President & CEO | 48 |
| Ms. Sharon F. O'Connor | Vice President of Legal Services | - |
| Melissa Storan | Vice President of Marketing | - |
| Jason Wheeler | Vice President of Sales & Account Management | - |
| Mr. Jeffrey D. Gurtcheff | Chief Claims Officer | - |
Riesgo de Auditoría
4
Riesgo del Consejo
6
Riesgo de Compensación
5
Riesgo de Derechos del Accionista
7
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Latest News
Recent headlines for CRVL, sourced from Markets Gazette.